|Population source||Exposure definition||Non-exposure definition||Sample size||Rmk|
2013 - 2015
|Pregnant women with a diagnosis of essential thrombocythemia (ET) with pregnancy outcome available.||Pregnancies in essential thrombocythemia (ET) women treated with Pegylated interferon alpha-2a (PEG-IFN).||
exposed to other treatment, sick
Previous pregnancies in the same women without use of Pegylated interferon alpha-2a (PEG-IFN).
|10 / 9||Other treatments in control group: low dose aspirin, ow molecular weight heparin (LMWH), IFN.|
4 studies, not fulfilled eligibility criteria, were excluded. See excluded tab for the list of these studies and reason of exclusion.